Marks Group Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.19M | Sell |
17,213
-1,089
| -6% | -$75.2K | 0.11% | 166 |
|
|
2025
Q1 | $1.27M | Sell |
18,302
-884
| -5% | -$61.4K | 0.12% | 162 |
|
|
2024
Q4 | $1.65M | Buy |
19,186
+308
| +2% | +$26.5K | 0.16% | 128 |
|
|
2024
Q3 | $2.25M | Sell |
18,878
-13
| -0.1% | -$1.55K | 0.21% | 120 |
|
|
2024
Q2 | $2.7M | Sell |
18,891
-1,008
| -5% | -$144K | 0.28% | 96 |
|
|
2024
Q1 | $2.56M | Sell |
19,899
-603
| -3% | -$77.4K | 0.27% | 99 |
|
|
2023
Q4 | $2.12M | Buy |
20,502
+106
| +0.5% | +$11K | 0.24% | 118 |
|
|
2023
Q3 | $1.85M | Sell |
20,396
-1,082
| -5% | -$98.4K | 0.23% | 125 |
|
|
2023
Q2 | $1.74M | Buy |
21,478
+3,968
| +23% | +$321K | 0.21% | 133 |
|
|
2023
Q1 | $1.39M | Buy |
17,510
+118
| +0.7% | +$9.39K | 0.18% | 137 |
|
|
2022
Q4 | $1.18M | Buy |
17,392
+704
| +4% | +$47.6K | 0.16% | 148 |
|
|
2022
Q3 | $832K | Sell |
16,688
-410
| -2% | -$20.4K | 0.13% | 169 |
|
|
2022
Q2 | $952K | Sell |
17,098
-7,362
| -30% | -$410K | 0.14% | 165 |
|
|
2022
Q1 | $1.36M | Buy |
24,460
+4,042
| +20% | +$224K | 0.17% | 132 |
|
|
2021
Q4 | $1.14M | Buy |
20,418
+8,880
| +77% | +$497K | 0.14% | 156 |
|
|
2021
Q3 | $552K | Buy |
11,538
+6,782
| +143% | +$324K | 0.07% | 197 |
|
|
2021
Q2 | $200K | Buy |
+4,756
| New | +$200K | 0.03% | 260 |
|